American Well (NYSE:AMWL) Announces Quarterly Earnings Results, Misses Expectations By $0.07 EPS

American Well (NYSE:AMWL) issued its earnings results on Wednesday. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.07), Zacks reports. The company had revenue of $59.52 million for the quarter, compared to analysts’ expectations of $61.10 million. American Well had a negative net margin of 260.63% and a negative return on equity of 40.19%. During the same quarter in the prior year, the company earned ($0.24) earnings per share. American Well updated its FY 2025 guidance to EPS and its FY 2024 guidance to EPS.

American Well Stock Performance

AMWL stock traded down $0.05 during midday trading on Thursday, reaching $0.48. 1,862,876 shares of the company traded hands, compared to its average volume of 1,979,117. American Well has a 52-week low of $0.45 and a 52-week high of $2.74. The business has a 50 day moving average of $0.80 and a 200-day moving average of $1.07. The firm has a market capitalization of $138.87 million, a price-to-earnings ratio of -0.21 and a beta of 1.12.

Insider Buying and Selling at American Well

In other news, EVP Vukasin Paunovich sold 251,323 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total value of $273,942.07. Following the sale, the executive vice president now directly owns 2,535,635 shares in the company, valued at $2,763,842.15. The sale was disclosed in a document filed with the SEC, which is available at this link. In other American Well news, EVP Vukasin Paunovich sold 251,323 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $273,942.07. Following the transaction, the executive vice president now directly owns 2,535,635 shares in the company, valued at approximately $2,763,842.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Robert Shepardson sold 319,214 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total value of $347,943.26. Following the transaction, the chief financial officer now owns 2,845,148 shares in the company, valued at $3,101,211.32. The disclosure for this sale can be found here. Insiders have sold a total of 1,158,186 shares of company stock worth $1,255,582 over the last ninety days. Company insiders own 12.94% of the company’s stock.

Analyst Ratings Changes

AMWL has been the subject of several research reports. Needham & Company LLC reissued a “hold” rating on shares of American Well in a research report on Thursday. Morgan Stanley reduced their price objective on American Well from $1.75 to $1.00 and set an “equal weight” rating for the company in a research report on Monday, April 15th.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.